GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
Market Cap$1.34B
Close$
$-56.72
143.5% downside
Current Fair Value
143.5% downsideOvervalued by 143.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.34 Billion |
|---|---|
| Enterprise Value | $1.33 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.23 |
| Beta | 2.38 |
| Outstanding Shares | 26,617,955 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.29 |
|---|---|
| PEG | 8.24 |
| Price to Sales | 10.02 |
| Price to Book Ratio | 13.03 |
| Enterprise Value to Revenue | 3.67 |
| Enterprise Value to EBIT | 407.64 |
| Enterprise Value to Net Income | 946 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About GeneDx Holdings Corp
3 employeesSema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and g...